| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/24/2003 | CA2454578A1 Modified human thymic stromal lymphopoietin |
| 04/23/2003 | EP1304382A2 Production of peptides in plants as viral coat protein fusions |
| 04/23/2003 | EP1304381A2 Process for producing hydrophobic polypeptides, proteins or peptides |
| 04/23/2003 | EP1303612A2 Streptococcus antigens |
| 04/23/2003 | EP1303611A2 Novel protein containing ring finger domaine r1p4 |
| 04/23/2003 | EP1303608A2 Zinc finger domain recognition code and uses thereof |
| 04/23/2003 | EP1303607A2 High affinity soluble interleukin-18 receptor |
| 04/23/2003 | EP1303606A2 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 04/23/2003 | EP1303604A2 Mammalian receptor proteins; related reagents and methods |
| 04/23/2003 | EP1303600A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/23/2003 | EP1303539A2 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 04/23/2003 | EP1303536A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 04/23/2003 | EP1303535A2 Protein complex serving as a vehicle for orally administerable medicaments |
| 04/23/2003 | EP1303533A2 Chimeric peptide immunogens, their preparation and use |
| 04/23/2003 | EP1303299A1 Compositions and methods for enhancing immunogenicity of antigens |
| 04/23/2003 | EP1250055A4 Immune modulation with death receptor-induced apoptosis |
| 04/23/2003 | EP1040351A4 C-terminal region of agouti-related transcript (art) protein |
| 04/23/2003 | EP0612348B1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 04/23/2003 | EP0546124B2 Multidomain hematopoiesis stimulators |
| 04/23/2003 | CN1412201A Monoclonal antibody for resisting human liver cancer and its application |
| 04/22/2003 | US6551991 Recombinant proteins derived from HGF and MSP |
| 04/22/2003 | US6551822 NL4 tie ligand homologue |
| 04/22/2003 | US6551773 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
| 04/22/2003 | US6551586 Merozoite surface antigen1 (MSA1); vaccinia virus expression vector which expresses a malaria MSA1 peptide in combination with a signal peptide and anchor peptide in a host animal |
| 04/22/2003 | CA2207741C Variants of human papilloma virus antigens |
| 04/22/2003 | CA2098295C G protein-coupled glutamate receptors |
| 04/22/2003 | CA2096975C Cell stress transcriptional factors |
| 04/22/2003 | CA2076386C Identification and expression of insect steroid receptor dna sequence |
| 04/22/2003 | CA1341427C Variants of immunoglobulin gene superfamily member |
| 04/17/2003 | WO2003031590A2 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 04/17/2003 | WO2003031589A2 Peptides and related compounds having thrombopoietic activity |
| 04/17/2003 | WO2003031477A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 04/17/2003 | WO2003031466A2 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/17/2003 | WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 04/17/2003 | WO2002050289A9 Methods for the production of multimeric proteins, and related compositions |
| 04/17/2003 | WO2002027327A3 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome |
| 04/17/2003 | WO2002024891A3 B7-like molecules and uses thereof |
| 04/17/2003 | WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 04/17/2003 | WO2002000721A3 Cytokine receptor zcytor17 |
| 04/17/2003 | WO2001098366A3 Enterokinase cleavage sequences and their use |
| 04/17/2003 | US20030073822 Blood group antigen fusion polypeptides and method of use thereof |
| 04/17/2003 | US20030073094 Stress proteins and uses therefor |
| 04/17/2003 | US20030072767 Compositions and methods for WT1 specific immunotherapy |
| 04/17/2003 | US20030072753 Virus-like particles for the induction of autoantibodies |
| 04/17/2003 | US20030072742 Enhancement of immune response using targeting molecules |
| 04/17/2003 | CA2461824A1 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 04/17/2003 | CA2461429A1 Peptides and related compounds having thrombopoietic activity |
| 04/17/2003 | CA2458392A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 04/16/2003 | EP1301613A2 Modified virus having an altered tropism |
| 04/16/2003 | EP1301606A1 Expression system |
| 04/16/2003 | EP1301605A2 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 04/16/2003 | EP1301604A2 Substrates and assays for beta-secretase activity |
| 04/16/2003 | EP1301599A2 Olfactory g-protein coupled receptor |
| 04/16/2003 | EP1301595A2 G-protein coupled receptors |
| 04/16/2003 | EP1301541A2 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| 04/16/2003 | EP1301540A2 Rgd (arg-gly-asp) coupled to neuropeptides |
| 04/16/2003 | EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 04/16/2003 | EP1301473A2 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation |
| 04/16/2003 | EP1200105A4 Modified factor viii |
| 04/16/2003 | EP0742796B1 Il-3 variant hematopoiesis fusion protein |
| 04/16/2003 | CN1411512A Chimeric immunogenic compositions and nucleir acids encoding them |
| 04/15/2003 | US6548653 Erythropoietin analog-human serum albumin fusion |
| 04/15/2003 | US6548642 Expression of synthetic genes designed from repetitive peptide sequences of hydroxyproline-rich glycoproteins |
| 04/15/2003 | US6548632 Fusions of scaffold proteins with random peptide libraries |
| 04/15/2003 | US6548482 Treatment of osteoporosis |
| 04/15/2003 | US6548249 Fusions of scaffold proteins with random peptide libraries |
| 04/15/2003 | US6548067 Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof |
| 04/10/2003 | WO2003029463A2 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/10/2003 | WO2003029462A1 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/10/2003 | WO2003029419A2 Three dimensional structure of crystalline grp94 binding domain, and its methods of use |
| 04/10/2003 | WO2003029409A2 Methods for generating, selecting, and identifying compounds which bind a target molecule |
| 04/10/2003 | WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy |
| 04/10/2003 | WO2003029286A1 Fluorescent proteins |
| 04/10/2003 | WO2003029282A2 Tumor-peptide antigens from the human prdi-bf1-protein |
| 04/10/2003 | WO2003028630A2 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/10/2003 | WO2003007971A9 Improved heteropolymer complexes and methods for their use |
| 04/10/2003 | WO2003002598A3 Peptides for use as translocation factors |
| 04/10/2003 | WO2002100348A8 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 04/10/2003 | WO2002098365A3 Conditioned cell culture media and uses thereof |
| 04/10/2003 | WO2002096467A3 Pharmaceutical use for secreted bacterial effector proteins |
| 04/10/2003 | WO2002059282A3 Adipocyte complement related protein zacrp13 |
| 04/10/2003 | WO2002050107A3 Streptococcus pyogenes antigens and corresponding dna fragments |
| 04/10/2003 | WO2002008396A3 Human proteases |
| 04/10/2003 | WO2002000174A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 04/10/2003 | WO2001073014A9 Human survivin interacting protein 1 (sip-1) |
| 04/10/2003 | US20030069398 Identification of human gaba transporter |
| 04/10/2003 | US20030069196 Ameliorating a symptom of an ischemic disorder or injury comprising administering a 200 gene product to ameliorate the symptom of the ischemic disorder or injury. |
| 04/10/2003 | US20030069181 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 04/10/2003 | US20030068678 WISP polypeptides and nucleic acids encoding same |
| 04/10/2003 | US20030068674 Method of producing a biosensor protein capable of regulating a fluorescence property of green fluorescent protein, and the biosensor protein produced by the method |
| 04/10/2003 | CA2462077A1 Fluorescent proteins |
| 04/10/2003 | CA2460916A1 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/10/2003 | CA2460396A1 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same |
| 04/10/2003 | CA2459133A1 Methods for generating, selecting, and identifying compounds which bind a target molecule |
| 04/09/2003 | EP1299728A2 Receptor assay for detecting an effect test compounds have on a particular membrane receptor |
| 04/09/2003 | EP1299545A2 Drug metabolizing enzymes |
| 04/09/2003 | EP1299540A2 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
| 04/09/2003 | EP1299538A2 Secreted proteins |
| 04/09/2003 | EP1299534A2 Grf2-binding proteins and applications thereof |
| 04/09/2003 | EP1299529A2 Conserved diaphanous-related formin autoregulatory domain (dad) |